FOEDRC Members receive Pappajohn Biomedical Institute Convergence Grants to support High-RIsk, High Reward

The Pappajohn Biomedical Institute at the University of Iowa has announced the winners of the first PBI-Convergence Seed Grant Competition. These awards will provide up to $100,000/year to each team for up to two years, to conduct collaborative studies between investigators in disparate fields and separate departments.

Congratulations to the Diabetes Research Center Faculty, who received these awards:
James Ankrum, Matthew Potthoff, Eric Taylor and Michael Welsh.

Funded proposals are summarized below:

Development of New Pharmacologic Agents for Treatment and Investigation of Compulsive Behavior
Andrew Pieper, psychiatry, and Gregory Friestad, chemistry.

Generation of a Novel Pharmacological Approach to Increase Adipose Tissue Thermogenesis
Matthew Potthoff, pharmacology, and James Ankrum, biomedical engineering.

Identifying Cystic Fibrosis Lung Disease Susceptibility Based on Chemical-Induced Gene Expression Signatures
Alejandro Pezzulo, internal medicine, Lee Joseph, internal medicine David Kristensen, biomedical engineering, Meng Wu, pharmacy, Michael Welsh, internal medicine, and Patrick Breheny, biostatistics CPH.

Targeted Modulation of Hepatic Mitochondrial Metabolism to Provide Ketogenic Protection from Epileptic Seizures
Gordon Buchanan, neurology, and Eric Taylor, biochemistry.

Convergence Pilot Grants reflect an important goal of the Pappajohn Biomedical Institute (PBI), which is to encourage investigators to cross boundaries between disciplines to obtain fundamental insight into biological systems and to apply that knowledge to human health. They are intended to bring together researchers in basic sciences, clinical sciences, engineering, and computer science for research that relates to the biosciences, biomedicine, and bioengineering.

To achieve this goal of enhancing interdisciplinary research, the PBI offers Convergence Seed Grants that will support innovative technology, basic research leading to fundamental discoveries, or novel applications. Seed funding for high-risk, high-reward collaborative proposals is intended to allow investigators to test the feasibility of their ideas. Funding may also increase investigators’ competitiveness for extramural grants, produce intellectual property, and generate start-ups. Proposals must be consistent with the PBI mission.

Monday, November 7, 2016